Mirapex and Methylphenidate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Mirapex (pramipexole dihydrochloride) and Methylphenidate (methylphenidate). Common drug interactions include nerve compression among females and abdominal neoplasm among males.

The phase IV clinical study analyzes what interactions people have when they take Mirapex and Methylphenidate. It is created by eHealthMe based on reports of 45 people who take the same drugs from the FDA, and is updated regularly.

What is Mirapex?

Mirapex has active ingredients of pramipexole dihydrochloride. It is often used in restless leg syndrome. eHealthMe is studying from 20,622 Mirapex users. Check the latest studies of Mirapex.

What is Methylphenidate?

Methylphenidate has active ingredients of methylphenidate. eHealthMe is studying from 8,217 Methylphenidate users. Check the latest studies of Methylphenidate.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 25, 2026

45 people who take Mirapex and Methylphenidate together, and have interactions are studied.

Mirapex and Methylphenidate drug interactions.

What are the common drug interactions of Mirapex and Methylphenidate, by gender? *:

female:

  1. Nerve compression
  2. Suicidal ideation
  3. Weight decreased
  4. Hospitalisation
  5. Anxiety
  6. Hypersensitivity
  7. Surgery
  8. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  9. Malaise (a feeling of general discomfort or uneasiness)
  10. Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)

male:

  1. Abdominal neoplasm (cancer of the stomach)
  2. Oesophageal adenocarcinoma (a cancer tumour of an epithelium in oesophagus)
  3. Umbilical hernia (an outward bulging (protrusion) of the abdominal lining or part of the abdominal organ(s) through the area around the belly button)

What are the common drug interactions of Mirapex and Methylphenidate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Back pain
  2. Fall
  3. Hypersensitivity
  4. Ligament injury
  5. Lower respiratory tract infection fungal
  6. Migraine (headache)
  7. Nerve compression
  8. Aphasia (damage to the parts of the brain that control language)
  9. Dependence
  10. Dyskinesia (abnormality or impairment of voluntary movement)

50-59:

  1. Rotator cuff syndrome (a spectrum of conditions affecting the rotator cuff tendons of the shoulder)
  2. Suicidal ideation
  3. Surgery
  4. Tooth disorder (tooth disease)
  5. Abdominal neoplasm (cancer of the stomach)
  6. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  7. Carpal tunnel syndrome (nerve compression at wrist results numbness weakness, pain , swelling)
  8. Chest pain
  9. Euphoric mood (excessively happy but may become angry or irritable)
  10. Fibromyalgia (a long-term condition which causes pain all over the body)

60+:

  1. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  2. Ankle fracture
  3. Hyperhidrosis (abnormally increased sweating)
  4. Oral herpes (viral infection of mouth)
  5. Therapeutic response unexpected
  6. Tooth extraction

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 35 people, 77.78%
  2. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 24 people, 53.33%
  3. Drowsiness: 6 people, 13.33%
  4. Pain: 4 people, 8.89%
  5. Breast Cancer Female: 3 people, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Mirapex and Methylphenidate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Mirapex and Methylphenidate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Mirapex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Methylphenidate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Mirapex and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Methylphenidate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on pramipexole dihydrochloride and methylphenidate (the active ingredients of Mirapex and Methylphenidate, respectively), and Mirapex and Methylphenidate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: